More: Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
More: Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
Read more: Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
See the article here: Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial...
Read more: Quality Smart Solutions Launches GRAS Experts to Protect Against Food Safety Risks
More here: Ultimovacs Announces Publication of Phase II FOCUS Trial Results on medRxiv
The rest is here: Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024...
Read this article: Helio Genomics and Halub Medical Co. Announce Strategic Partnership to Commercialize HelioLiver Dx in The Gulf Cooperation Council and Middle East
More: ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement
Recent Comments